Clinical Trials Directory

Trials / Terminated

TerminatedNCT00295737

Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma

05/04 IMHOTEP-1 FHG: Ex Vivo Effect of an Immunotoxin on Activated Human Macrophages From Atopics After Segmental Instillation of Allergen and Endotoxin

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Fraunhofer-Institute of Toxicology and Experimental Medicine · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to isolate macrophages by using bronchoalveolar lavage (BAL) for different in vitro experiments. Therefore, following a baseline BAL, allergen, endotoxin, and saline will be instilled into three different lung segments during the first bronchoscopy. After 24 hours during a second bronchoscopy, BAL fluid will be collected in these challenged segments to harvest invaded cells for in vitro experimentation. In addition, segmental bronchial biopsies will be taken to assess the degree of local inflammation.

Conditions

Interventions

TypeNameDescription
PROCEDUREbronchoscopy, allergen/endotoxin instillation

Timeline

Start date
2006-02-01
Primary completion
2008-01-01
Completion
2008-01-01
First posted
2006-02-24
Last updated
2008-01-16

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00295737. Inclusion in this directory is not an endorsement.